Bronchial asthma is a chronic disease that affects individuals of all ages. It has a high
prevalence and is associated with high morbidity and considerable levels of mortality …

Asthma is a major non-communicable disease characterized by recurrent attacks of
breathlessness and wheezing. According to World Health Organization (WHO), it is …

Metabolomics has been increasingly explored to achieve an improved understanding of
asthma. In the current observational and exploratory study, the first to have examined the …

Asthma is the most common chronic airway inflammation, with multiple phenotypes caused
by complicated interactions of genetic, epigenetic, and environmental factors. To date …

Asthma and airway inflammation are responses to infectious stimuli and the mechanisms of
how they are mediated, whether by the innate or adaptive immune response systems, are …

Asthma is a complex disease well-suited to metabolomic profiling, both for the development
of novel biomarkers and for the improved understanding of pathophysiology. In this review …

Metabolomics can be used to explore altered metabolic pathways in asthma, giving insights
into its pathophysiology. We aimed to review how metabolomics has been used to …

Asthma is a heterogenous disorder driven by inflammatory mechanisms that result in
multiple phenotypes. Given the complex nature of this condition, metabolomics is being …

Objective Asthma and chronic obstructive pulmonary disease (COPD) feature different
inflammatory and cellular profiles in the airways, indicating that the cellular metabolic …

Background and Objective. Asthma as a chronic heterogeneous disease seriously affects
the quality of life. Incorrect identification for its clinical phenotypes lead to a huge waste of …